{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:49:13Z","timestamp":1788749353683,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Education, South Korea","award":["RS-2023-00243810"],"award-info":[{"award-number":["RS-2023-00243810"]}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2022-NR070671"],"award-info":[{"award-number":["RS-2022-NR070671"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010955","name":"GemVax and KAEL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00702-025-03091-y","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:09:16Z","timestamp":1766988556000},"page":"1531-1542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Distinct plasma inflammatory signatures reflect disease severity and progression in progressive supranuclear palsy: a prospective cohort study"],"prefix":"10.1007","volume":"133","author":[{"given":"Ryul","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Hyeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beomseok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"6","key":"3091_CR1","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1093\/brain\/awac471","volume":"146","author":"NE Adams","year":"2023","unstructured":"Adams NE, Jafarian A, Perry A et al (2023) Neurophysiological consequences of synapse loss in progressive supranuclear palsy. Brain 146(6):2584\u20132594","journal-title":"Brain"},{"key":"3091_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fnins.2020.00893","volume":"14","author":"P Alster","year":"2020","unstructured":"Alster P, Madetko N, Koziorowski D, Friedman A (2020) Microglial activation and inflammation as a factor in the pathogenesis of progressive supranuclear palsy (PSP). Front Neurosci 14:893","journal-title":"Front Neurosci"},{"issue":"7","key":"3091_CR3","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1007\/s00415-024-12350-z","volume":"271","author":"JA Black","year":"2024","unstructured":"Black JA, Pham NTT, Ali F, Machulda MM, Lowe VJ, Josephs KA, Whitwell JL (2024) Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants. J Neurol 271(7):4267\u20134280","journal-title":"J Neurol"},{"key":"3091_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1742-2094-8-65","volume":"8","author":"P Boss\u00f9","year":"2011","unstructured":"Boss\u00f9 P, Salani F, Alberici A et al (2011) Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J Neuroinflammation 8:65","journal-title":"J Neuroinflammation"},{"issue":"7","key":"3091_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552\u2013563","journal-title":"Lancet Neurol"},{"issue":"3","key":"3091_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/ars.2020.8076","volume":"33","author":"C Cervellati","year":"2020","unstructured":"Cervellati C, Trentini A, Pecorelli A, Valacchi G (2020) Inflammation in neurological disorders: the thin boundary between brain and periphery. Antioxid Redox Signal 33(3):191\u2013210","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"3091_CR7","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1093\/brain\/awad181","volume":"146","author":"NB Dadario","year":"2023","unstructured":"Dadario NB, Sughrue ME (2023) The functional role of the precuneus. Brain 146(9):3598\u20133607","journal-title":"Brain"},{"key":"3091_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2018.06.018","volume":"56","author":"L Donker Kaat","year":"2018","unstructured":"Donker Kaat L, Meeter LH, Chiu WZ et al (2018) Serum neurofilament light chain in progressive supranuclear palsy. Parkinsonism Relat Disord 56:98\u2013101","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3091_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52025-x","volume":"15","author":"K Farrell","year":"2024","unstructured":"Farrell K, Humphrey J, Chang T et al (2024) Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. Nat Commun 15(1):7880","journal-title":"Nat Commun"},{"key":"3091_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.parkreldis.2011.06.007","volume":"17","author":"R Fern\u00e1ndez-Botr\u00e1n","year":"2011","unstructured":"Fern\u00e1ndez-Botr\u00e1n R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson DW, Litvan I (2011) Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism Relat Disord 17:683\u2013688","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"3091_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac113","volume":"4","author":"N Franzmeier","year":"2022","unstructured":"Franzmeier N, H\u00f6glinger GU (2022) Inferring the sequence of brain volume changes in progressive supranuclear palsy using MRI. Brain Commun 4(3):fcac113","journal-title":"Brain Commun"},{"issue":"3","key":"3091_CR12","doi-asserted-by":"publisher","first-page":"1603e1","DOI":"10.1016\/j.neurobiolaging.2014.10.023","volume":"36","author":"L Gibbons","year":"2015","unstructured":"Gibbons L, Rollinson S, Thompson JC et al (2015) Plasma levels of progranulin and interleukin-6 in frontotemporal Lobar degeneration. Neurobiol Aging 36(3):1603e1\u20131603e4","journal-title":"Neurobiol Aging"},{"issue":"11","key":"3091_CR13","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ et al (2016) Tau positron emission tomographic imaging in the lewy body diseases. JAMA Neurol 73(11):1334\u20131341","journal-title":"JAMA Neurol"},{"issue":"1","key":"3091_CR14","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","volume":"8","author":"S Hall","year":"2018","unstructured":"Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O (2018) Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Sci Rep 8(1):13276","journal-title":"Sci Rep"},{"issue":"2","key":"3091_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-022-02445-0","volume":"144","author":"D Hermans","year":"2022","unstructured":"Hermans D, Houben E, Baeten P et al (2022) Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity. Acta Neuropathol 144(2):259\u2013281","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3091_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853\u2013864","journal-title":"Mov Disord"},{"issue":"4","key":"3091_CR17","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3233\/JAD-215327","volume":"88","author":"E Howard","year":"2022","unstructured":"Howard E, Ballinger S, Kinney NG et al (2022) Frontal atrophy and executive dysfunction relate to complex numbers impairment in progressive supranuclear palsy. J Alzheimers Dis 88(4):1553\u20131566","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"3091_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/jnen\/60.6.647","volume":"60","author":"K Ishizawa","year":"2001","unstructured":"Ishizawa K, Dickson DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol 60(6):647\u2013657","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"3091_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00702-023-02613-w","volume":"130","author":"KA Jellinger","year":"2023","unstructured":"Jellinger KA (2023) Pathomechanisms of cognitive impairment in progressive supranuclear palsy. J Neural Transm 130(4):481\u2013493","journal-title":"J Neural Transm"},{"issue":"9","key":"3091_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/mds.22583","volume":"24","author":"M Kanazawa","year":"2009","unstructured":"Kanazawa M, Shimohata T, Toyoshima Y et al (2009) Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord 24(9):1312\u20131318","journal-title":"Mov Disord"},{"issue":"2","key":"3091_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ et al (2020) Distribution patterns of Tau pathology in progressive supranuclear palsy. Acta Neuropathol 140(2):99\u2013119","journal-title":"Acta Neuropathol"},{"issue":"10","key":"3091_CR22","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","volume":"88","author":"KSP Lai","year":"2017","unstructured":"Lai KSP, Liu CS, Rau A et al (2017) Peripheral inflammatory markers in Alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry 88(10):876\u2013882","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3091_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107301","volume":"132","author":"S Lee","year":"2025","unstructured":"Lee S, Kim H, Kim R et al (2025) Application of elastic net for clinical outcome prediction and classification in progressive supranuclear palsy: a multicenter cohort study. Parkinsonism Relat Disord 132:107301","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"3091_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/PSY.0000000000000148","volume":"77","author":"MA Lindquist","year":"2015","unstructured":"Lindquist MA, Mejia A (2015) Zen and the art of multiple comparisons. Psychosom Med 77(2):114\u2013125","journal-title":"Psychosom Med"},{"issue":"5","key":"3091_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/mds.29769","volume":"39","author":"JH Ma","year":"2024","unstructured":"Ma JH, Dong C, Qiao HW et al (2024) Striatal and extrastriatal monoaminergic disruption in progressive supranuclear palsy. Mov Disord 39(5):847\u2013854","journal-title":"Mov Disord"},{"issue":"20","key":"3091_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015135","volume":"24","author":"N Madetko-Alster","year":"2023","unstructured":"Madetko-Alster N, Otto-\u015alusarczyk D, Wierci\u0144ska-Drapa\u0142o A et al (2023) Clinical phenotypes of progressive supranuclear palsy-the differences in interleukin patterns. Int J Mol Sci 24(20):15135","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3091_CR27","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","volume":"86","author":"NK Magdalinou","year":"2015","unstructured":"Magdalinou NK, Paterson RW, Schott JM et al (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 86(11):1240\u20131247","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"3091_CR28","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/ana.25911","volume":"88","author":"M Malpetti","year":"2020","unstructured":"Malpetti M, Passamonti L, Rittman T et al (2020) Neuroinflammation and tau colocalize in vivo in progressive supranuclear palsy. Ann Neurol 88(6):1194\u20131204","journal-title":"Ann Neurol"},{"issue":"7","key":"3091_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jnnp-2020-325549","volume":"92","author":"M Malpetti","year":"2021","unstructured":"Malpetti M, Passamonti L, Jones PS et al (2021) Neuroinflammation predicts disease progression in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 92(7):769\u2013775","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3091_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/awae269","volume":"148","author":"M Malpetti","year":"2025","unstructured":"Malpetti M, Swann P, Tsvetanov KA et al (2025) Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration. Brain 148(2):493\u2013505","journal-title":"Brain"},{"issue":"4","key":"3091_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dinarello CA, Molgora M, Garlanda C (2019) Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity 50(4):778\u2013795","journal-title":"Immunity"},{"issue":"8","key":"3091_CR32","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00221-017-4978-4","volume":"235","author":"G N\u00fcbling","year":"2017","unstructured":"N\u00fcbling G, Schuberth M, Feldmer K, Giese A, Holdt LM, Teupser D, Lorenzl S (2017) Cathepsin S increases Tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative Tauopathy progressive supranuclear palsy. Exp Brain Res 235(8):2407\u20132412","journal-title":"Exp Brain Res"},{"key":"3091_CR33","doi-asserted-by":"crossref","unstructured":"Painous C, Fern\u00e1ndez M, C\u00e1mara A et al (2025) Barcelona progressive supranuclear palsy (PSP) registry: clinical, oculomotor, and cerebrospinal fluid markers; from suggestive to definite cases. Mov Disord [Epub ahead of print]","DOI":"10.1002\/mds.70086"},{"key":"3091_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102408","volume":"28","author":"C Palmisano","year":"2020","unstructured":"Palmisano C, Todisco M, Marotta G et al (2020) Gait initiation in progressive supranuclear palsy: brain metabolic correlates. Neuroimage Clin 28:102408","journal-title":"Neuroimage Clin"},{"issue":"3","key":"3091_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00401-010-0722-x","volume":"120","author":"VH Perry","year":"2010","unstructured":"Perry VH (2010) Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 120(3):277\u2013286","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3091_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00449-5","volume":"9","author":"Y Qu","year":"2023","unstructured":"Qu Y, Li J, Qin Q et al (2023) A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):18","journal-title":"NPJ Parkinsons Dis"},{"issue":"14","key":"3091_CR37","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C et al (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29(14):1758\u20131766","journal-title":"Mov Disord"},{"issue":"3","key":"3091_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/acn3.290","volume":"3","author":"JC Rojas","year":"2016","unstructured":"Rojas JC, Karydas A, Bang J et al (2016) Plasma neurofilament light chain predicts progression in progressive supranuclear palsy. Ann Clin Transl Neurol 3(3):216\u2013225","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"3091_CR39","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1212\/WNL.0000000000004859","volume":"90","author":"JC Rojas","year":"2018","unstructured":"Rojas JC, Bang J, Lobach IV et al (2018) CSF neurofilament light chain and phosphorylated Tau 181 predict disease progression in PSP. Neurology 90(4):e273\u2013e281","journal-title":"Neurology"},{"issue":"6 Pt A","key":"3091_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","volume":"1863","author":"M Rothaug","year":"2016","unstructured":"Rothaug M, Becker-Pauly C, Rose-John S (2016) The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta 1863(6 Pt A):1218\u20131227","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3091_CR41","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.1038\/s41598-019-44234-y","volume":"9","author":"R Rydbirk","year":"2019","unstructured":"Rydbirk R, Elfving B, Folke J, Pakkenberg B, Winge K, Brudek T, Aznar S (2019) Increased prefrontal cortex interleukin-2 protein levels and shift in the peripheral T cell population in progressive supranuclear palsy patients. Sci Rep 9(1):7781","journal-title":"Sci Rep"},{"issue":"1","key":"3091_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.24052","volume":"75","author":"CS Scherling","year":"2014","unstructured":"Scherling CS, Hall T, Berisha F et al (2014) Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol 75(1):116\u2013126","journal-title":"Ann Neurol"},{"issue":"4","key":"3091_CR43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s11064-023-04085-6","volume":"49","author":"C Shan","year":"2024","unstructured":"Shan C, Zhang C, Zhang C (2024) The role of IL-6 in neurodegenerative disorders. Neurochem Res 49(4):834\u2013846","journal-title":"Neurochem Res"},{"key":"3091_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102850","volume":"32","author":"I Sintini","year":"2021","unstructured":"Sintini I, Kaufman K, Botha H et al (2021) Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy. NeuroImage: Clinical 32:102850","journal-title":"NeuroImage: Clinical"},{"issue":"1","key":"3091_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf051","volume":"7","author":"C Spiegel","year":"2025","unstructured":"Spiegel C, Marotta C, Bertram K, Vivash L, Harding IH (2025) Brainstem and cerebellar radiological findings in progressive supranuclear palsy. Brain Commun 7(1):fcaf051","journal-title":"Brain Commun"},{"issue":"10","key":"3091_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-021-00541-5","volume":"17","author":"M Stamelou","year":"2021","unstructured":"Stamelou M, Respondek G, Giagkou N, Whitwell JL, Kovacs GG, H\u00f6glinger GU (2021) Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies. Nat Rev Neurol 17(10):601\u2013620","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3091_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12974-018-1339-6","volume":"15","author":"C Starhof","year":"2018","unstructured":"Starhof C, Winge K, Heegaard NHH, Skogstrand K, Friis S, Hejl A (2018) Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes. J Neuroinflammation 15(1):305","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3091_CR48","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1523\/JNEUROSCI.4227-13.2014","volume":"34","author":"AV Utevsky","year":"2014","unstructured":"Utevsky AV, Smith DV, Huettel SA (2014) Precuneus is a functional core of the default-mode network. J Neurosci 34(3):932\u2013940","journal-title":"J Neurosci"},{"issue":"3","key":"3091_CR49","doi-asserted-by":"publisher","first-page":"152892","DOI":"10.1016\/j.imbio.2025.152892","volume":"230","author":"J Wang","year":"2025","unstructured":"Wang J, Forrest SL, Dasari S et al (2025) Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy. Immunobiology 230(3):152892","journal-title":"Immunobiology"},{"key":"3091_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J et al (2021) Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics 20:100168","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"3091_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1212\/WNL.0b013e318223c79d","volume":"77","author":"A Zwergal","year":"2011","unstructured":"Zwergal A, la Foug\u00e8re C, Lorenzl S et al (2011) Postural imbalance and falls in PSP correlate with functional pathology of the thalamus. Neurology 77(2):101\u2013109","journal-title":"Neurology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03091-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:07:08Z","timestamp":1785600428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03091-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3091"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03091-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}